The North America Point of Care Diagnostics Market is witnessing continued development due to the growing need for quick and accessible diagnostic testing. Advanced healthcare systems in the US and Canada are supporting the adoption of technologies that allow testing to be performed near patients rather than relying solely on centralized laboratories. These solutions help shorten testing times and facilitate faster treatment decisions.

According to The Insight Partners, The Point of Care Diagnostics Market size is projected to reach US$ 88.83 billion by 2031 from US$ 37.93 billion in 2024. The market is estimated to register a CAGR of 13.0% during 2024–2031. The strong growth trajectory reflects increasing demand for rapid diagnostic testing, technological advancements in point-of-care platforms, and the growing shift toward decentralized healthcare delivery. Point-of-care diagnostics enable healthcare professionals to perform tests close to the patient and receive results more rapidly than through many conventional laboratory workflows. This capability is particularly valuable in emergency and primary care environments where timely diagnosis can influence treatment decisions.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00006394

The increasing adoption of molecular diagnostics, immunoassays, clinical chemistry testing, glucose monitoring, and other rapid testing technologies is contributing to market development. In addition, healthcare providers are increasingly emphasizing early diagnosis, disease monitoring, and personalized treatment approaches. These factors, together with the expansion of healthcare services in emerging economies and continued innovation by diagnostic technology manufacturers, are expected to create significant opportunities in the point-of-care diagnostics market through 2031.

Point of Care Diagnostics Market: Key Trends

• Growing demand for rapid testing: Healthcare providers are increasingly adopting diagnostic solutions that deliver results within minutes or a short period to support timely clinical decisions.
• Shift toward decentralized healthcare: Testing is increasingly moving from centralized laboratories to hospitals, clinics, physician offices, pharmacies, ambulatory centers, and home-care environments.
• Technological advancements: Innovations in molecular diagnostics, biosensors, microfluidics, digital connectivity, and portable analyzers are improving point-of-care testing capabilities.
• Rising chronic disease burden: The increasing prevalence of diabetes, cardiovascular diseases, infectious diseases, and other chronic conditions is driving demand for continuous and accessible diagnostic monitoring.
• Integration with digital healthcare: Connected diagnostic devices and digital platforms are supporting data sharing, remote monitoring, and more efficient patient management.
• Increasing home-based testing: Greater emphasis on self-monitoring and home healthcare is creating opportunities for easy-to-use point-of-care diagnostic technologies.

Point of Care Diagnostics Market Size, Share, Trends, Analysis, and Forecast by 2031

• Market Size (2024): US$ 37.93 billion
• Projected Market Size (2031): US$ 88.83 billion
• CAGR (2024–2031): 13.0%
• Forecast Period: 2024–2031
• Major Growth Factors: Rising chronic disease burden, demand for rapid diagnosis, technological advancements, decentralized healthcare delivery, and increasing adoption of home-based testing.

Regional Analysis

The Point of Care Diagnostics Market is analyzed across North America, Europe, Asia Pacific, the Middle East Africa, and South and Central America. North America represents a significant market supported by advanced healthcare infrastructure, high healthcare expenditure, rapid technology adoption, and the presence of major diagnostic companies. Europe is experiencing growth due to increasing demand for early disease detection, expanding healthcare services, and the adoption of advanced diagnostic technologies. Asia Pacific is expected to offer substantial growth opportunities owing to increasing healthcare investments, rising disease prevalence, improving healthcare infrastructure, and growing awareness of rapid diagnostic testing. The Middle East Africa market is supported by efforts to improve diagnostic access and healthcare infrastructure, while South and Central America are witnessing increasing demand for accessible and decentralized diagnostic solutions.

Key Players in the Point of Care Diagnostics Market

• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories Inc
• Abbott Laboratories
• QIAGEN NV
• Siemens AG
• BD
• bioMérieux SA
• Polymer Technology Systems, Inc. (PTS)
• Nova Biomedical Corporation
• Danaher Corp

These companies are focusing on product development, technological innovation, strategic collaborations, acquisitions, and geographic expansion to strengthen their positions in the point-of-care diagnostics market. Investments in portable testing platforms, molecular diagnostics, connected devices, and rapid testing technologies are expected to remain important competitive strategies.

About Us

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish